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The influence of tourniquet use and operative time on
the incidence of deep vein thrombosis in total knee
arthroplasty
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OBJECTIVE: To evaluate the association between tourniquet and total operative time during total knee arthroplasty
and the occurrence of deep vein thrombosis.
METHODS: Seventy-eight consecutive patients from our institution underwent cemented total knee arthroplasty for
degenerative knee disorders. The pneumatic tourniquet time and total operative time were recorded in minutes.
Four categories were established for total tourniquet time: ,60, 61 to 90, 91 to 120, and .120 minutes. Three
categories were defined for operative time: ,120, 121 to 150, and .150 minutes. Between 7 and 12 days after
surgery, the patients underwent ascending venography to evaluate the presence of distal or proximal deep vein
thrombosis. We evaluated the association between the tourniquet time and total operative time and the occurrence
of deep vein thrombosis after total knee arthroplasty.
RESULTS: In total, 33 cases (42.3%) were positive for deep vein thrombosis; 13 (16.7%) cases involved the proximal
type. We found no statistically significant difference in tourniquet time or operative time between patients with or
without deep vein thrombosis. We did observe a higher frequency of proximal deep vein thrombosis in patients
who underwent surgery lasting longer than 120 minutes. The mean total operative time was also higher in patients
with proximal deep vein thrombosis. The tourniquet time did not significantly differ in these patients.
CONCLUSION: We concluded that surgery lasting longer than 120 minutes increases the risk of proximal deep vein
thrombosis.
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INTRODUCTION
The induction of deep vein thrombosis (DVT) following
total knee arthroplasties (TKAs) and total hip arthroplasties
is frequently studied (1), although DVT also results from
other knee procedures (2). Despite the importance of and
interest in this problem, most researchers studying DVT
generally focus on postoperative prophylaxis. Surprisingly,
few studies have investigated the isolated risk factors for
DVT associated with TKA. Although controversy exists
regarding the role of TKA alone as a risk factor for DVT (3–
7), some researchers believe that bone manipulation, ream-
ing of the medullary canal, and the operative time are
relevant risk factors for DVT (8,9). Another important and
controversial factor related to TKA is the use of surgical
tourniquets. Although all of these factors are mentioned in
the literature, operative time has received little attention as
an isolated risk factor for DVT in TKA.
We used ascending venography (AV) to determine the
presence of proximal and distal DVT after TKA and
evaluated the association between tourniquet time and
TKA operative time and the occurrence of DVT.
PATIENTS AND METHODS
Seventy-eight consecutive patients from our institution
underwent cemented TKA for degenerative knee disorders.
Of the 78 patients, 78.2% were women and 21.8% were men,
with an average age of 65.1 years (range, 31–88 years; SD,
11.5 years). Osteoarthrosis was the diagnosis in 74.4% of the
cases, rheumatoid arthritis in 21.8%, and other disorders in
the remaining 3.8%.
All total knee arthroplasties were performed with the
same technique. An intramedullary guide was used for
distal femoral osteotomy. An extramedullary guide was
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used for proximal tibial osteotomy. We recorded the total
pneumatic tourniquet time and total operative time in
minutes. In all cases, the use of a tourniquet was interrupted
for hemostasis after the implant was cemented and before
wound closure. Four categories were established for total
tourniquet time: ,60, 61 to 90, 91 to 120, and .120 minutes.
The total operative time was consistently defined as the time
from the initial incision to the last suture stitch made to
close the incision. Three categories were defined for
operative time: ,120, 121 to 150, and .150 minutes. Only
two patients (3.1%) were administered a general anesthetic;
all other patients received a spinal block. All patients
received DVT prophylaxis with oral anticoagulants for 12
days, with an international normalized ratio maintained at
approximately 2.5 (range, 2.0–3.0) in all cases (10).
An ascending venography, for which the patients
provided informed consent, was performed between 7 and
12 days after surgery after discharge from the hospital. The
study end point was defined based on the execution of
bilateral AV. The AV was performed by a specialist in
vascular radiology. The technique applied was performed
essentially as described by Rabinov and Paulin (11). The
presence of clinically manifested DVT and/or pulmonary
embolism was also considered. The clinical manifestations
of DVT were defined as follows: greater edema of the
affected lower limb than would be expected for the
procedure, intense pain on palpation of the calf, and pain
on passive dorsiflexion of the foot. An AV finding that was
considered to be positive for DVT was the presence of blood
clots in the vein lumens (Figure 1). DVTs were characterized
as occurring on the operated side, on the contralateral side
or bilaterally and were classified as proximal or distal DVT.
We used the chi-squared test for the comparison of
qualitative variables between groups. For the quantitative
variables, we used Levene’s test to determine the homo-
geneity of variances and the Kolmogorov-Smirnov test to
determine the normality of the distribution. In cases in
which both conditions were met, the averages of both
groups were compared using Student’s t-test. A level of
significance of 5% was adopted in the analyses. The
statistical program used was SPSS (SPSS for Windows,
release 6.0, SPSS Inc., Chicago, IL, USA).
RESULTS
We found that 45 patients (57.7%) had negative bilateral
AV, and 33 (42.3%) had DVT. Thirteen patients (16.7%) had
a proximal DVT. We compared the patients with DVT with
those without DVT. We also compared the cases with
proximal DVT with the cases involving distal DVT and the
cases with normal findings on AV.
The baseline characteristics of our patients are summar-
ized in Table 1. We observed that patients with DVT were
older than patients without DVT (62.9¡12.3 vs 68.2¡9.7
years, respectively; p= 0.04). When we compared only the
patients with proximal DVT with the other patients, we
found no difference in age between the groups (64.3¡12.0
vs 69.2¡7.8 years, respectively; p= 0.2). We also observed
that osteoarthritis was the most frequent diagnosis and was
found in almost 90% of patients with DVT.
The total population did not demonstrate any statically
significant differences in tourniquet or total operative time
based on the presence or absence of DVT, as shown in
Table 2. Considering only patients with proximal DVT, we
found no significant difference in tourniquet time (p= 0.08).
For total operative time, we observed a significant difference
between the groups, with a higher frequency of proximal
DVT in patients with an operative time that was longer than
120 minutes (p= 0.05) (Table 3). Patients with proximal DVT
also had a higher mean operative time (146.9¡20.4 vs
127.9¡22.4 min, respectively; p= 0.01) (Table 4).
DISCUSSION
The systematic reviews of DVT in TKA almost exclusively
address therapeutic alternatives for this condition (12–15);
few reviews address the risk factors. We believe that
undergoing TKA is itself a risk factor for DVT (3–
5,12,16,17). One of the few reports that contradict this
hypothesis is a report by Fowkes et al. (18), which addresses
the general aspects of the incidence of DVT, reporting it as
approximately 10,000 persons/year in the general popula-
tion. Bhandari et al. (19) warned that the inherent limitations
of those studies and the lack of attention to other risk factors
render these reports of limited value. Gross et al. (20) noted
that studies on DVT prophylaxis have demonstrated a low
incidence of DVT complications after total hip arthroplasty
and TKA, which is far below the incidences that were initially
reported in venography studies conducted to detect asymp-
tomatic DVT. Improving the techniques used in perioperative
orthopedic care should reduce thromboembolic complica-
tions, regardless of prophylaxis. According to Bergqvist et al.
Figure 1 - An ascending venogram of a patient after total knee
arthroplasty showing deep vein thrombosis (arrows) in the lower
limb.
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(1), the incidence of DVT is higher after TKA than after total
hip arthroplasty.
Although many authors accept the possibility of DVT
with these procedures, others no longer consider this
complication to be a serious problem (21,22). Some authors
believe that mechanical prophylaxis, even with limited
resources, is adequate in all cases of TKA (23–25), whereas
others believe that pharmacologic prophylaxis in arthro-
plasty is indicated in select cases according to the individual
risk for DVT (26). We agree with the view of Haas et al. (14);
although there is no ideal prophylaxis, a multimodal
approach that combines pharmacologic therapy with
mechanical prophylaxis has proven to be safe and effective.
The number of studies that clearly define the risk factors
for DVT in TKA remains small. Surgical and orthopedic
aspects, such as the duration of tourniquet use and
operative time, are not identified as risk factors by some
authors (6,7).
The frequency of DVT observed in TKA varies from 20.3%
to 84%, regardless of prophylaxis. In the proximal form of
DVT, these values range from 4.4% to 20% (6,27–30). In our
study, we observed only one case of clinical DVT, which
made statistical analysis unfeasible. Although most studies
report small numbers of patients with symptomatic DVT,
Wang et al. (28) observed this clinical phenomenon in up to
70% of cases. There were no cases of pulmonary embolism
in the present study. The frequency of pulmonary embolism
has been reported to be low, varying between 0 and 20%
(31,32), but most studies have reported that the frequency is
approximately 1% (6,33,34). In our analyses, we only
considered cases of general DVT and proximal DVT, which
were specifically studied because these forms are consid-
ered to potentially have more severe complications
(30,35,36).
Data related to the surgical procedure itself are always
important to orthopedists. The most optimal moment at
which the surgical technique can be evaluated and modified
for the patient’s benefit is during the operation. The type of
anesthesia used is certainly one of the most frequently
evaluated topics in the literature, although some doubts
remain regarding the effects of anesthesia type on DVT
incidence. Researchers have studied epidural block alone
versus general anesthesia, and most data suggest that
epidural block should be protective against DVT (29,37–
40). However, in a recent article, Macfarlane et al. (41)
questioned these results. Evaluating anesthesia in isolation
was not the objective of our study. The high frequency of
spinal blocks in the present study (96.9%) can be attributed
to the routines of the anesthesia service. Thus, it was not
possible to detect the influence of the type of anesthesia on
the occurrence of DVT.
Table 1 - Patient baseline characteristics.
Population Without DVT With DVT p-value
Gender
no. (%) Male 17 (21.8) 11 (24.4) 6 (18.2) 0.51
Female 61 (78.2) 34 (75.6) 27 (81.8)
Age Mean (range) 65.1 (31-88) 62.9 (31-88) 68.2(39-82) 0.04*
Ethnic group
no. (%) White 56 (71.8) 30 (66.7) 26 (78.8)
Black 14 (17.9) 11 (24.4) 3 (9.1) 0.21
Other 8 (10.3) 4 (8.9) 4 (12.1)
Diagnosis
no. (%) Osteoarthritis 58 (74.4) 29 (64.4) 29 (87.9)
Rheumatoid arthritis 17 (21.8) 14 (31.1) 3 (9.1) 0.05*
Other 3 (3.8) 2 (4.4) 1 (3.0)
BMI Mean (range) 29.2 (18.5-48.3) 29.2 (18.5-41.4) 29.3 (21-48.3) 0.95
*significant p-value.
BMI - body mass index.
Table 2 - The population distribution based on
tourniquet (n =74) and operative times (n= 78) and a
comparative analysis of patients with and without DVT.
Variable No. of Patients (%) p-value
Population Without DVT With DVT
Tourniquet time
(min)
,60 6 (8.1) 3 (7.0) 3 (9.7) 0.19
61–90 33 (44.6) 21 (48.8) 12 (38.7)
91–120 32 (43.2) 19 (44.2) 13 (41.9)
121–150 3 (4.1) — 3 (9.7)
Surgery time (min)
,120 24 (31.1) 16 (35.6) 8 (24.2) 0.56
121–150 43 (53.8) 23 (51.1) 20 (60.6)
.150 11 (14.1) 6 (13.3) 5 (15.2)
Chi-squared test.
DVT, deep vein thrombosis.
Table 3 - The population distribution by tourniquet
(n= 74) and operative times (n= 78) and a comparative
analysis of patients with and without proximal DVT.
Variable No. of Patients (%) p-value
Without
Proximal DVT
With Proximal
DVT
Tourniquet time (min)
,60 5 (8.1) 1 (8.3) 0.08
61–90 27 (43.5) 6 (50.0)
91–120 29 (46.8) 3 (25.0)
121–150 1 (1.6) 2 (16.7)
Surgery time (min)
,120 23 (35.4) 1 (7.7) 0.05*
121–150 35 (53.8) 8 (61.5)
.150 7 (10.8) 4 (30.8)
Chi-squared test; *significant value.
DVT, deep vein thrombosis.
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Wilson et al. (42) stated that traction of blood vessels,
which are more constricted closer to the bone as a result of
the tourniquet, increases the likelihood of blood vessel
lesions. Wauke et al. (43) postulated that the use of
tourniquets may be associated with the occurrence of
DVT, although they did not present any concrete data to
support this theory. In evaluating our data, we did not
observe any significant results regarding the overall
presence of DVT in relation to a longer tourniquet time.
In our analysis of patients with proximal DVT, we
observed a higher likelihood of DVT with longer tourniquet
times, but this association was not statistically significant
(p=0.08). This observation lends some support to the
findings of Abdel-Salam and Eyres (48), who reported a
greater number of patients with proximal DVT when
tourniquets were used.
Total operative time was considered to be significantly
associated with the incidence of proximal DVTs, which as
mentioned earlier, are considered to be the more severe
DVT type (30,35,36). A report by Stringer et al. (2) was the
only report we found indicating that the total operative time
is a risk factor, although it did not define the cutoff point for
operative time. Our data enabled us to conclude that a total
operative time of .2 hours is correlated with a higher
frequency of proximal DVT. The results of the analysis of
these variables when considered as continuous categories
for total operative time generated a p-value of 0.01, which
further reinforces our findings.
Although this study has provided some interesting
findings, it also has some limitations. We performed a
case-control study, an observational study in which patients
were selected on the basis of whether they have the disorder
under study, in this case, DVT. Because this type of study
does not involve direct experimentation or variable manip-
ulation, the validity of the statistical association between
exposure and disease must be made under conditions that
are not strictly controlled (49). Therefore, a priori power
analysis and sample size determination were not per-
formed. We observed differences between the groups
concerning age and diagnosis. Patients with DVT were
older than patients without DVT. This observation lends
some support to the findings of Markovic-Denic et al. (50),
who reported that age is a significant risk factor for DVT.
Considering only patients with proximal DVT, we found no
difference between the groups. We believe that, for this
subgroup of patients, a longer operative time is an
important risk factor for DVT.
Despite our conviction concerning the link between
operative time and DVT, which was confirmed by our
findings, we do not recommended rushing the surgical
procedure in an attempt to shorten it because other equally
severe problems, such as poor component alignment, poor
ligament balance, and unsatisfactory homeostasis, may
develop. We believe that the most effective way to shorten
surgery is detailed planning, discipline, and familiarization
of the surgical team with the surgical instruments. We
should note that our institution is a training center for large
numbers of medical residents, who perform many TKAs.
We conclude that a total operative time of .120 minutes,
which is generally sufficient for a careful procedure in the
majority of TKAs, increases the risk of proximal DVT, and
although our findings were not statistically significant, a
tourniquet time of .90 minutes should be considered as a
possible risk factor for proximal DVT.
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